rf-fullcolor.png

 

January 13, 2021
by Michael Mezher

European Commission appoints members to MDR/IVDR expert panels

The European Commission this week released the names of members appointed to its 12 expert panels on medical devices and in vitro diagnostics (IVDs).
 
The expert panels, established under the Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), will provide scientific, technical and clinical input to the Commission, its Medical Device Coordination Group (MDCG), member states, notified bodies and manufacturers. In particular, notified bodies are required to consult with expert panels on the clinical evaluations of certain high risk medical devices and performance evaluations of some high-risk IVDs.
 
Membership in the 11 device and IVD-focused panels ranges from just two members to 28 members, while the screening panel, which is tasked with determining whether there is a need for a scientific opinion, boasts 70 members. So far, the Commission has not named the panel chairs and vice chairs, who will make up the expert panel coordination committee.
 
Expert Panel Members
Screening panel 70
Orthopaedics, traumatology, rehabilitation, rheumatology 24
Circulatory system 28
Neurology 15
Respiratory system, anaesthesiology, intensive care 5
Endocrinology and diabetes 2
General and plastic surgery and dentistry 15
Obstetrics and gynaecology, including reproductive medicine 2
Gastroenterology and hepatology 5
Nephrology and urology 5
Ophthalmology 4
In vitro diagnostic medical devices 28
 
A central list of qualified experts who have not been appointed to an expert panel has also been published with 170 experts identified.
 
European Commission
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.